In most cancers, STAT3 is overactivated and promotes tumor progression by regulating various biological processes, such as proliferation, apoptosis, angiogenesis, and immune response, which are generally associated with poor clinical prognosis [10,14−17]. The gene discussed is STAT3; the disease is cancer.